Erenumab-aooe for Temporomandibular Disorders Management: TMD Cgrp Antibody RElief (TMD CARE)

Clinical trial NCT05162027 · TERMINATED

Trial details

NCT number: NCT05162027
Sponsor: University of Maryland, Baltimore
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Temporomandibular Disorders

Start date: 2022-05-26
Primary completion: 2023-01-03
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.